The FDA has granted accelerated approval to two Alzheimer’s drugs so far. Eli Lilly’s amyloid plaque-busting therapy won’t become the third. The Lilly drug still has a chance to pass regulatory muster, but it will take more data and more time.
Lilly announced the complete response letter…
Source: medcitynews.com – Read more
M&S boss urges shoppers to visit stores in person as it battles cyber-attack – The Guardian
Marks & Spencer’s CEO, Stuart Machin, apologized for recent service disruptions caused by a cyber attack, assuring customers that the company is working tirelessly to
